161 Aufrufe 161 0 Kommentare 0 Kommentare

    Early Warning Press Release of Evonik Venture Capital GmbH

    Vancouver, British Columbia--(Newsfile Corp. - September 10, 2024) - Evonik Venture Capital GmbH ("Evonik"), an entity controlled by Evonik Industries AG, a publicly-listed German company, holds 10,004,415 common shares ("Common Shares") and 94,500 common share purchase warrants (the "Warrants") in the capital of FRX Innovations Inc. (the "Company").

    On March 1, 2024, the Company announced the completion of a non-brokered private placement offering (the "Offering") of 18,906,266 units of the Company. Each unit consisted of one Common Share of the Company and one Warrant of the Company. Evonik did not participate in the Offering.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Evonik Industries AG!
    Long
    18,85€
    Basispreis
    2,24
    Ask
    × 9,31
    Hebel
    Zum Produkt
    Short
    23,20€
    Basispreis
    0,24
    Ask
    × 9,13
    Hebel
    Zum Produkt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Prior to the Offering, Evonik held an aggregate of 10,004,415 Common Shares and 94,500 Warrants, representing approximately 10.05% of the Company's issued and outstanding Common Shares on a non-diluted basis and approximately 10.14% on a partially diluted basis, assuming exercise of the Warrants.

    Following the completion of the Offering, Evonik's Common Shares and Warrants represent approximately 8.4% of the Company's issued and outstanding securities on a non-diluted basis, and approximately 8.5% on a partially diluted basis, assuming exercise of Evonik's Warrants. As a result, Evonik no longer has beneficial ownership of, or control or direction over, voting or equity securities of the Company or securities convertible into voting or equity securities of any class of the Company that, together with Evonik's securities of that class, would constitute 10% or more of the outstanding securities of that class.

    The foregoing disclosure is being disseminated pursuant to National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting. Copies of the associated early warning report with respect to the foregoing will be filed on the Company's profile on SEDAR+ at www.sedarplus.com.

    For more information, please contact:

    Holger Seier

    Head of Innovation Marketing
    Email: holger.seier@evonik.com

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/222945



    Diskutieren Sie über die enthaltenen Werte


    newsfile
    0 Follower
    Autor folgen

    Verfasst von newsfile
    Early Warning Press Release of Evonik Venture Capital GmbH Vancouver, British Columbia--(Newsfile Corp. - September 10, 2024) - Evonik Venture Capital GmbH ("Evonik"), an entity controlled by Evonik Industries AG, a publicly-listed German company, holds 10,004,415 common shares ("Common Shares") and 94,500 …